Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2025-12-27 @ 3:04 PM
Study NCT ID:
NCT06068868
Status:
TERMINATED
Last Update Posted:
2025-03-06
First Post:
2023-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-29
First Submit QC Date:
None
Study First Post Date:
2023-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-06
Last Update Post Date Type:
ACTUAL